Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
8	8	Search

2025	Mechanism of ruxolitinib enhancing mitophagy against renal fibrosis via PINK1/Parkin pathway Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease He Li, Peipei Meng, Yuhang Meng, Yige Yang, Wensheng Zheng, Hongdong Huang, Zhigang Zhao
2025	Mechanisms of Xuefu Zhuyu decoction in treating diabetic kidney disease-induced renal fibrosis: UPLC-Q/TOF-MS, network pharmacology, and experimental validation The Korean Journal of Physiology & Pharmacology Yifei Zhang, Shuaixing Zhang, Zeyu Zhang, Zijing Cao, Xuehui Bai, Shujiao Zhang, Mengqi Zhou, Jingyi Tang, Yiran Xie, Zhongjie Liu, Weijing Liu, Yuning Liu
2025	Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression Cells Nikola Pavlović, Marinela Križanac, Marko Kumrić, Katarina Vukojević, Joško Božić
2025	Mitochondria-targeting therapeutic strategies for chronic kidney disease Biochemical Pharmacology Annie Sun, Carol A. Pollock, Chunling Huang
2025	Autophagy: a double-edged sword in ischemia–reperfusion injury Cellular & Molecular Biology Letters Lingxuan Tang, Wangzheqi Zhang, Yan Liao, Weijie Wang, Xiaoming Deng, Changli Wang, Wenwen Shi
2025	Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease? Frontiers in Nutrition Jiang Bai, Lijuan Zhang, Letian He, Yun Zhou
2024	Insights into the role of mitophagy in lung cancer: current evidence and perspectives Frontiers in Pharmacology Xin Zhang, Dongzhi Yu, Peng Tang, Fengshou Chen
2024	Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney disease Frontiers in Cell and Developmental Biology Kaiqing Li, Xue Xia, Ying Tong